弥漫大B细胞淋巴瘤患者临床特征及预后分析
|
|
赵洁, 姜言, 郝思国
|
Clinical characteristics and prognosis of patients with diffuse large B-cell lymphoma
|
|
ZHAO Jie, JIANG Yan, HAO Siguo
|
|
表1 DLBCL患者基本临床特征 （n=160）
|
Tab 1 General clinical features of patients with DLBCL （n=160）
|
|
| Variable | Patients/n(%) |
|---|
| Gender | | | Male | 88 (55.0) | | Female | 72 (45.0) | | Age | | | ≤60 years | 73 (45.6) | | >60 years | 87 (54.4) | | Group B symptoms | | | No | 87 (54.4) | | Yes | 73 (45.6) | | Hans classification | | | GCB | 56 (35.0) | | Non-GCB | 104 (65.0) | | ECOG score | | | <2 scores | 117 (73.1) | | ≥2 scores | 43 (26.9) | | Ann Arbor stage | | | Ⅰ‒Ⅱ | 63 (39.4) | | Ⅲ‒Ⅳ | 97 (60.6) | | IPI score | | | 0‒2 scores | 70 (43.8) | | 3‒5 scores | 90 (56.2) | | LDH level | | | ≤211 U·L-1 | 51 (31.9) | | >211 U·L-1 | 109 (68.1) | | Albumin level | | | ≥35 g·L-1 | 123 (76.9) | | <35 g·L-1 | 37 (23.1) | | Absolute lymphocyte level | | | >1.1×109·L-1 | 104 (65.0) | | ≤1.1×109·L-1 | 56 (35.0) | | Anemia | | | No | 106 (66.2) | | Yes | 54 (33.8) | | Chemotherapy regimen | | | R-CHOP | 147 (91.9) | | CHOP | 13 (8.1) |
|
|
|